XTL Biopharmaceuticals
(NASDAQ:XTLB)
$2.97
0.44[17.39%]
Last update: 6:57AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

XTL Biopharmaceuticals Stock (NASDAQ:XTLB), Quotes and News Summary

XTL Biopharmaceuticals Stock (NASDAQ: XTLB) stock price, news, charts, stock research, profile.

Open$2.530
Close-
Volume / Avg.8.807K / 761.944K
Day Range2.390 - 2.570
52 Wk Range0.750 - 4.990
Market Cap$16.184M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest-
Days to Cover1

Recent News

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Avi Kapoor
Dow Surges 350 Points; Fed Holds Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also rose, gaining, 0.78% to 5,218.70.
Avi Kapoor
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
XTLB
IMRN

FAQ

Q

How do I buy XTL Biopharmaceuticals (XTLB) stock?

A

You can purchase shares of XTL Biopharmaceuticals (NASDAQ: XTLB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are XTL Biopharmaceuticals's (XTLB) competitors?

A

Other companies in XTL Biopharmaceuticals’s space includes: Immuron (NASDAQ:IMRN), Vaxxinity (NASDAQ:VAXX), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).

Q

What is the target price for XTL Biopharmaceuticals (XTLB) stock?

A

The latest price target for XTL Biopharmaceuticals (NASDAQ: XTLB) was reported by HC Wainwright & Co. on Friday, May 8, 2015. The analyst firm set a price target for 6.00 expecting XTLB to rise to within 12 months (a possible 146.90% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for XTL Biopharmaceuticals (XTLB)?

A

The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $2.4301 last updated Today at May 6, 2024 at 3:15 PM EDT.

Q

Does XTL Biopharmaceuticals (XTLB) pay a dividend?

A

There are no upcoming dividends for XTL Biopharmaceuticals.

Q

When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?

A

XTL Biopharmaceuticals does not have any upcoming earnings scheduled.

Q

Is XTL Biopharmaceuticals (XTLB) going to split?

A

There is no upcoming split for XTL Biopharmaceuticals.

Q

What sector and industry does XTL Biopharmaceuticals (XTLB) operate in?

A

XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch